| Trial ID: | L7264 |
| Source ID: | NCT01249677
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: insulin glargine
|
| Outcome Measures: |
Primary: Improvements in first and second phase insulin secretion, Improvements in first and second phase insulin secretion after bedtime administration of insulin glargin, titrated to reach normal (90-100 mg/dl) fasting glucose levels, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Ruhr University of Bochum
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01
|
| Completion Date: |
2010-05
|
| Results First Posted: |
|
| Last Update Posted: |
2010-11-30
|
| Locations: |
Department of Medicine I; University Hospital St. Josef Hospital, Bochum, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01249677
|
